Nkgen Biotech Common Stock Price Prediction
| NKGN Stock | 0.05 0.01 9.09% |
Momentum 58
Buy Extended
Oversold | Overbought |
Using NKGen Biotech, hype-based prediction, you can estimate the value of NKGen Biotech Common from the perspective of NKGen Biotech, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in NKGen Biotech, to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying NKGen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NKGen Biotech, after-hype prediction price | USD 0.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NKGen |
NKGen Biotech, After-Hype Price Prediction Density Analysis
As far as predicting the price of NKGen Biotech, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NKGen Biotech, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of NKGen Biotech,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NKGen Biotech, Estimiated After-Hype Price Volatility
In the context of predicting NKGen Biotech,'s pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NKGen Biotech,'s historical news coverage. NKGen Biotech,'s after-hype downside and upside margins for the prediction period are 0.00 and 52.55, respectively. We have considered NKGen Biotech,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NKGen Biotech, is out of control at this time. Analysis and calculation of next after-hype price of NKGen Biotech Common is based on 3 months time horizon.
NKGen Biotech, Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as NKGen Biotech, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NKGen Biotech, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NKGen Biotech,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
16.77 | 59.84 | 0.00 | 9.09 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.05 | 0.05 | 0.00 |
|
NKGen Biotech, Hype Timeline
NKGen Biotech Common is now traded for 0.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -9.09. NKGen is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 16.77%. %. The volatility of related hype on NKGen Biotech, is about 11040.59%, with the expected price after the next announcement by competition of -9.04. About 39.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 3.42. NKGen Biotech Common had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out NKGen Biotech, Basic Forecasting Models to cross-verify your projections.NKGen Biotech, Related Hype Analysis
Having access to credible news sources related to NKGen Biotech,'s direct competition is more important than ever and may enhance your ability to predict NKGen Biotech,'s future price movements. Getting to know how NKGen Biotech,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NKGen Biotech, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| WINT | Windtree Therapeutics | (0.02) | 7 per month | 0.00 | (0.05) | 20.00 | (20.00) | 58.33 | |
| ELAB | Elevai Labs Common | (5.35) | 1 per month | 0.00 | (0.13) | 5.71 | (14.03) | 103.11 | |
| BCTXZ | BriaCell Therapeutics Corp | 0.00 | 0 per month | 0.00 | (0.06) | 15.38 | (15.91) | 49.00 | |
| PTIX | Protagenic Therapeutics | (0.17) | 7 per month | 0.00 | (0.29) | 9.38 | (8.72) | 24.38 | |
| XRTX | XORTX Therapeutics | 0.04 | 11 per month | 0.00 | (0.05) | 9.09 | (8.33) | 61.23 | |
| MLEC | Moolec Science SA | 0.00 | 0 per month | 0.00 | (0.24) | 8.89 | (10.81) | 44.59 | |
| VRAX | Virax Biolabs Group | (0.02) | 10 per month | 0.00 | (0.03) | 7.89 | (10.20) | 92.80 | |
| DRMA | Dermata Therapeutics | 0.10 | 9 per month | 0.00 | (0.15) | 11.11 | (10.23) | 37.70 | |
| NCEL | NewcelX | 0.00 | 0 per month | 0.00 | (0.35) | 10.00 | (16.98) | 39.40 | |
| ATXI | Avenue Therapeutics | 0.00 | 0 per month | 6.40 | (0.01) | 12.66 | (14.29) | 39.28 |
NKGen Biotech, Additional Predictive Modules
Most predictive techniques to examine NKGen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NKGen using various technical indicators. When you analyze NKGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NKGen Biotech, Predictive Indicators
The successful prediction of NKGen Biotech, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NKGen Biotech Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NKGen Biotech, based on analysis of NKGen Biotech, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NKGen Biotech,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NKGen Biotech,'s related companies.
Story Coverage note for NKGen Biotech,
The number of cover stories for NKGen Biotech, depends on current market conditions and NKGen Biotech,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NKGen Biotech, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NKGen Biotech,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
NKGen Biotech, Short Properties
NKGen Biotech,'s future price predictability will typically decrease when NKGen Biotech,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NKGen Biotech Common often depends not only on the future outlook of the potential NKGen Biotech,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NKGen Biotech,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.4 M | |
| Cash And Short Term Investments | 26 K | |
| Shares Float | 17.8 M |
Other Information on Investing in NKGen Pink Sheet
NKGen Biotech, financial ratios help investors to determine whether NKGen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NKGen with respect to the benefits of owning NKGen Biotech, security.